Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Cancer Survival Analysis01:21

Cancer Survival Analysis

797
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
797

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and Evaluation of the Personal Patient Profile-Bladder Cancer (P3-BC): A Web-Based Decision Support System for Patients Considering Cystectomy and Urinary Diversion.

Cancers·2026
Same author

User-Centered Development of the MyCare<sup>2</sup> Comprehensive Digital Support Platform for Caregivers of Individuals With Cancer.

JCO clinical cancer informatics·2026
Same author

Understanding what surgical advanced practice providers want: A survey of autonomy, tasks, and training preferences across three institutions.

American journal of surgery·2026
Same author

Updates to Early Detection of Prostate Cancer: AUA/SUO Guideline (2026).

The Journal of urology·2026
Same author

A web-based application to promote palliative care in advanced ovarian cancer: A pre-post design.

Gynecologic oncology reports·2026
Same author

Real-World Utility of Cxbladder Triage for Patients with Microhematuria: A Matched Cohort Study.

Urology practice·2026
Same journal

Editorial Comment.

The Journal of urology·2026
Same journal

Editorial Comment.

The Journal of urology·2026
Same journal

Editorial Comment.

The Journal of urology·2026
Same journal

Uro-Science.

The Journal of urology·2026
Same journal

Editorial Comment.

The Journal of urology·2026
Same journal

Editorial Comment.

The Journal of urology·2026
See all related articles

Related Experiment Video

Updated: Feb 25, 2026

A New Technique for Treating Low-risk Prostate Cancer&#8212;Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

925

Decision Support with the Personal Patient Profile-Prostate: A Multicenter Randomized Trial.

Donna L Berry1, Fangxin Hong1, Traci M Blonquist1

  • 1Dana-Farber Cancer Institute at St. Elizabeth's Medical Center, Boston, Massachusetts.

The Journal of Urology
|July 30, 2017
PubMed
Summary
This summary is machine-generated.

The Personal Patient Profile-Prostate (P3P) decision aid significantly reduced decisional conflict in men with localized prostate cancer compared to usual care. This web-based tool supports shared decision-making for prostate cancer patients.

Keywords:
decision support techniquesmedical informaticsplanning techniquesprostatic neoplasmssurveys and questionnaires

More Related Videos

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

1.3K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.2K

Related Experiment Videos

Last Updated: Feb 25, 2026

A New Technique for Treating Low-risk Prostate Cancer&#8212;Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

925
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

1.3K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.2K

Area of Science:

  • Urology
  • Health Informatics
  • Decision Science

Background:

  • Localized prostate cancer presents complex treatment decisions for patients.
  • Shared decision-making is crucial for patient-centered prostate cancer care.
  • Existing decision aids require evaluation for efficacy in diverse patient populations.

Purpose of the Study:

  • To evaluate the efficacy of the web-based Personal Patient Profile-Prostate (P3P) decision aid.
  • To compare decisional conflict in men with localized prostate cancer using P3P versus usual care.
  • To identify factors influencing decisional conflict in this patient group.

Main Methods:

  • A randomized controlled trial with 392 men with localized prostate cancer.
  • Intervention group received P3P decision aid; control group received usual care.
  • Decisional conflict was measured at 1 month using validated scales.

Main Results:

  • The P3P decision aid group showed significantly reduced decisional conflict (-5.00, 95% CI -9.40--0.59).
  • Mean decisional conflict scores were 10.9 ± 16.7 for intervention and 9.9 ± 18.0 for usual care.
  • Predictors of conflict included income, marital status, decision status, consultations, site, and risk classification.

Conclusions:

  • The P3P decision aid is an effective adjunct for shared decision-making in localized prostate cancer.
  • Risk classification, consultations, and resources significantly impacted decisional conflict.
  • Web-based decision aids can improve patient engagement and reduce conflict in cancer care.